Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_assertion type Assertion NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_head.
- NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_assertion description "[A reportedly selective Met-kinase inhibitor (SU-11274) markedly affected the growth of MET-KD cancer cells, indicating this compound exerts its effects not only through the intended target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_provenance.
- NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_assertion evidence source_evidence_literature NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_provenance.
- NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_assertion SIO_000772 17595299 NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_provenance.
- NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_assertion wasDerivedFrom befree-20150227 NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_provenance.
- NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_assertion wasGeneratedBy ECO_0000203 NP802909.RAQ3ISSRnd0fJ2J_a3HoJA8zDIg-sV_MtbTNLB_YbNocE130_provenance.